News and Trends 27 Mar 2018 A New Liquid Biopsy Can Improve Ovarian Cancer Diagnosis Angle, a UK-based biotech, is developing a non-invasive liquid biopsy that could be better than current diagnostic methods at predicting ovarian cancer. Angle, a company specializing in liquid biopsies, has shown that its Pelvic Mass Triage (PMT) liquid biopsy test can differentiate between benign and cancerous pelvic masses and ovarian cysts in 95% of cases […] March 27, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 27 Mar 2018 Stem Cell Therapy for Crohn’s Disease Approved in Europe Developed by TiGenix, Alofisel is the first stem cell therapy made out of donor stem cells to receive a marketing authorization in Europe. The European Commission has approved Alofisel (darvadstrocel), a stem cell therapy to treat complex perianal fistulas — one of the most disabling complications of Crohn’s disease. The cell therapy represents an alternative to multiple surgeries […] March 27, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Mar 2018 New Antibiotic for Urinary Tract Infections Gets Positive Phase II Results Allecra Therapeutics has obtained positive Phase II study results for its new urinary tract infection antibiotic, supporting the launch of a Phase III trial. Allecra Therapeutics, a French-German biotech, has obtained positive Phase II trial results for its lead antibiotic candidate for treating urinary tract infections. The drug, AAU101, was given to patients intravenously with cefepemine, another antibiotic […] March 26, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2018 Biotech VC Goes After Disrupting Animal Health and Nutrition The French biotech VC Seventure, known for its investments in microbiome health, has launched a €24M fund focused on companies developing animal health and nutrition applications. A new venture capital fund called AVF has been launched today to support animal health and nutrition companies. With €24M at its first closing, the fund created by Seventure Partners in partnership […] March 23, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 23 Mar 2018 Researchers Give Sight to the Blind With Stem Cell Patch UK researchers have successfully restored vision in two blind patients by transplanting a stem cell patch into their eyes. Scientists at University College London and Moorfields Eye Hospital, London, have used a stem cell patch to successfully restore vision in two patients with age-related macular degeneration (AMD) in a Phase I trial. Following the stem […] March 23, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 22 Mar 2018 French Biotech Signs a Deal to Fight Antibiotic Resistance Deinove is licensing a portfolio of antibiotics for multi-drug resistant bacteria from Redx Pharma. Deinove, based in Montpellier, France, has signed an agreement to use synthetic molecules developed by UK biotech Redx to treat lethal anitbiotic-resistant infections. Redx’s molecules are a new class of antibiotics targeting an enzyme involved in bacterial DNA replication in Gram-negative bacteria. Deinove plans to […] March 22, 2018 - 1 minutemin - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2018 A Personalized Genetic Test for Breast Cancer Arrives in Europe Agendia will launch a next-generation sequencing test in the EU to determine the chances of metastasis in breast cancer patients. Agendia, a US-Dutch biotech specializing in personalized medicine and molecular diagnostics, has obtained CE marking for the MammaPrint BluePrint Kit, a diagnostic device for breast cancer that uses next-generation sequencing technology. The kit can help clinicians identify […] March 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2018 DNA Sequencing Unicorn Oxford Nanopore Raises £100M Round at £1.5Bn Valuation Undeterred by competitors, Oxford Nanopore, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next-generation sequencing platform. Oxford Nanopore is one of the best-funded biotechs in Europe, having raised £507.3M (€578M) in total, and famous for its “DNA-reading gadget the size of a Mars bar that sells for $1,000.” The company plans to […] March 20, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2018 Oxford Firm Develops Better Test for ALS Diagnosis Oxford BioDynamics has presented data from a new diagnostic test that could help not just diagnose ALS but also help patients get a personalized treatment. Amyotrophic lateral sclerosis (ALS) is a motor neuron disease whose diagnosis comes with the hard news that most patients die merely within 3 to 5 years of diagnosis. One of […] March 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 19 Mar 2018 Early Research in Bone Marrow Transplants Could Treat ALS Early stage research from Spain could lead to a treatment for amyotrophic lateral sclerosis (ALS) using adult stem cells from bone marrow to stop progressive muscle paralysis. Researchers from the Neuroscience Institute at the Universidad Miguel Hernández (UMH) in Elche, Alicante, and the Spanish National Research Council (CSIC) aim to test a stem cell treatment for […] March 19, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 19 Mar 2018 This French Device Could Repair Holes in the Heart HoliStick Medical, a Paris-based startup, is developing a novel catheter device that can repair holes in the heart without the use of sutures. HoliStick Medical, has gained the exclusive rights to develop a catheter device created by Harvard University and MIT. The catheter is designed to repair holes and tissue defects in the heart and other […] March 19, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 16 Mar 2018 Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if the Swiss company’s Parkinson’s treatment proves successful. Danish pharma Lundbeck has decided to boost its pipeline with the acquisition of Prexton Therapeutics. The deal grants Lundbeck with global rights to foliglurax, a drug to reduce the “off” time periods when Parkinson’s motor […] March 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email